glp-1 drug coverage As more Americans turn to drugs for weight loss, Medicare is launching a limited program to expand access for eligible beneficiaries GLP-1 insurance coverage worsened at
Description
Endocrinology 158: 4139-4151, 2017
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes and, more recently, approved for weight management
Additional safety considerations include caution in patients with severe gastroparesis, and a potential risk of diabetic retinopathy complications with rapid glucose improvement, particularly with semaglutide
Two studies (Dao et al
95%CI: 0.800.93) as well as in terms of the three individual components (cardiovascular death, myocardial infarction, and stroke)
